{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1093/bioinformatics/btv031",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.tools/assign",
      "@type": "sc:SoftwareApplication",
      "edam:has_input": [
        {
          "@id": "edam:data_3112"
        },
        {
          "@id": "edam:data_2600"
        }
      ],
      "edam:has_output": [
        {
          "@id": "edam:data_1772"
        },
        {
          "@id": "edam:data_2600"
        }
      ],
      "sc:additionalType": [
        "Library",
        "Command-line tool"
      ],
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0602"
        },
        {
          "@id": "edam:topic_2269"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1093/bioinformatics/btv031"
      },
      "sc:description": "Tool to evaluate the pathway deregulation/activation status in patient samples. It employs a Bayesian factor analysis approach to adapt predetermined pathway signatures derived from knowledge-based literatures or from perturbation experiments to the cell-/tissue-specific pathway signatures. The deregulation/activation level of each context-specific pathway is quantified to a score, which represents the extent to which a patient sample encompasses the pathway deregulation/activation signature.",
      "sc:featureList": {
        "@id": "edam:operation_0533"
      },
      "sc:license": "MIT",
      "sc:name": "ASSIGN",
      "sc:url": "http://bioconductor.org/packages/release/bioc/html/ASSIGN.html",
      "sc:version": "1.10.0"
    }
  ]
}